Chargement en cours...

TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis

Preclinical data support the potential of the death-signaling receptors for TRAIL as targets for cancer therapy. However, it is unclear whether these death-signaling receptors suppress the emergence and growth of malignant tumors in vivo. Herein we show that TNF-related apoptosis-inducing ligand rec...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Finnberg, Niklas, Klein-Szanto, Andres J.P., El-Deiry, Wafik S.
Format: Artigo
Langue:Inglês
Publié: American Society for Clinical Investigation 2007
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2129232/
https://ncbi.nlm.nih.gov/pubmed/18079962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI29900
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!